Clinical effectiveness and safety of escitalopram and desvenlafaxine in patients of depression with anxiety: A randomized, open-label controlled trial

AIM: Selective serotonin reuptake inhibitors (SSRI) and serotonin-norepinephrine reuptake inhibitors (SNRI) are effective in treating anxiety disorders associated with major depressive disorder (MDD). This randomized, controlled, parallel-group, open-label, phase 4 trial (CTRI/2012/08/002895) was un...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Maity, Nabakumar, Ghosal, Malay Kumar, Gupta, Anupam, Sil, Amrita, Chakraborty, Sushmita, Chatterjee, Suparna
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2014
Assuntos:
Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4118540/
https://ncbi.nlm.nih.gov/pubmed/25097285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.135959
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados